Cello Group: Cello Group eyeing further US healthcare expansion in 2018

Mark Scott, chief executive of Cello Group plc (LON:CLL) caught up with Proactive Investors to discuss their 2017 update. Scott says the group traded well in the period with continued strong growth from their Cello Health division. The group successfully integrated two US acquisitions into Cello Health, which augmented like-for-like growth, as a result of which the group expects to report a full-year result in line with expectations. Bookings in late 2017 that relate to ongoing 2018 work were strong, providing good momentum going into the New Year Scott adds that Cello Signal, which provides "web-centred marketing solutions for big corporates" in the technology, gaming, retail, consumer goods and charities sectors, continued to make solid progress against its strategic goals.